Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A
- PMID: 3882281
- PMCID: PMC1577167
Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A
Abstract
Oral administration of cyclosporin A (Cy A), an immunosuppressive agent, prolonged the life span of female NZB/NZW (F1) hybrid mice (NZB/W). The most prominent feature of this study was the reduction of glomerular proliferation, proteinurea, and delay of renal failure. Protection from renal damage, in treated mice, occurred despite similar degrees of perivascular cellular infiltration in the kidney and other organs, and glomerular deposition of immunoglobulin and complement. Treatment did not influence the hypergammaglobulinaemia, high levels of circulating immune complexes and later development of autoimmune haemolytic anaemia typically associated with this murine disease. The levels of antibodies to double stranded DNA (dsDNA), an important disease marker, and the response to sheep red blood cells were reduced in the Cy A treated mice, in contrast with the untreated mice. Levels of rheumatoid factors were increased in Cy A treated mice, when compared with untreated mice, and this could play a role in prolongation of life associated with protection from glomerular damage, although it was considered that inhibitory effects on T cell function were a more likely mechanism.
Similar articles
-
Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.Prog Clin Biol Res. 1987;229:157-74. Prog Clin Biol Res. 1987. PMID: 3601985
-
Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.Arthritis Rheum. 2005 Nov;52(11):3629-38. doi: 10.1002/art.21379. Arthritis Rheum. 2005. PMID: 16255055
-
Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice.Clin Exp Immunol. 1983 Nov;54(2):359-65. Clin Exp Immunol. 1983. PMID: 6360436 Free PMC article.
-
Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.Clin Exp Immunol. 1984 Dec;58(3):694-702. Clin Exp Immunol. 1984. PMID: 6334582 Free PMC article.
-
Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.Clin Exp Immunol. 1986 May;64(2):225-33. Clin Exp Immunol. 1986. PMID: 3488856 Free PMC article.
Cited by
-
Cyclophosphamide and 15(S)-15 methyl PGE1 correct the T/B lymphocyte ratios of NZB/NZW mice.Agents Actions. 1990 Mar;29(3-4):333-41. doi: 10.1007/BF01966466. Agents Actions. 1990. PMID: 2339673
-
Suppression of autoimmune disease in NZB/W F1 mice by treatment with the novel immunomodulator BTS 63155.Clin Exp Immunol. 1993 Sep;93(3):313-7. doi: 10.1111/j.1365-2249.1993.tb08178.x. Clin Exp Immunol. 1993. PMID: 8370159 Free PMC article.
-
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.Drugs. 1993 Jun;45(6):953-1040. doi: 10.2165/00003495-199345060-00007. Drugs. 1993. PMID: 7691501 Review.
-
Inhibition of in vitro NZB antibody responses by cyclosporine.Clin Exp Immunol. 1988 Jan;71(1):155-8. Clin Exp Immunol. 1988. PMID: 3258202 Free PMC article.
-
Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.Clin Exp Immunol. 1986 May;64(2):234-42. Clin Exp Immunol. 1986. PMID: 3742874 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources